Rapid Micro Biosystems (RPID) Preferred Stock Liabilities (2020 - 2021)
Rapid Micro Biosystems (RPID) posted Preferred Stock Liabilities of $235.8 million for Q2 2021, up 0.86% sequentially from $233.8 million in Q1 2021, and up 60.1% YoY from $147.3 million in Q2 2020.
Rapid Micro Biosystems (RPID) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Rapid Micro Biosystems has reported Preferred Stock Liabilities for 2 years, with the latest figure at $235.8 million in Q2 2021.
- Quarterly Preferred Stock Liabilities rose 60.1% year-over-year to $235.8 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $235.8 million (up 60.1% YoY) and the FY2020 annual result came in at $151.8 million, changed N/A from the prior year.
- Preferred Stock Liabilities grew to $235.8 million in Q2 2021 per RPID's latest filing, from $233.8 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $235.8 million in Q2 2021 and troughed at $147.3 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Rapid Micro Biosystems | 81.71 Mn | 61.94 Mn | 1.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 235.84 Mn |
| Mar 31, 2021 | 233.83 Mn |
| Dec 31, 2020 | 151.83 Mn |
| Sep 30, 2020 | 149.55 Mn |
| Jun 30, 2020 | 147.31 Mn |